Pfizer and French Partner Seek Approval for Lyme Disease Vaccine
Pfizer, in collaboration with French partner Valneva, announced its intention to seek regulatory approval for a Lyme disease vaccine after successful advanced clinical trials. This initiative comes amid growing interest in new methods to combat this globally significant health threat.